Buy Stocks Easy | About Us
August 4, 2020
Buy Stocks Easy | Online Stocks

SRPT


Buy Sarepta Therapeutics, Inc. Stock (symbol: SRPT) Easy Online

Company Name: Sarepta Therapeutics, Inc.

Symbol: SRPT

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2000

SRPT Current Share Price

Today's SRPT ( Sarepta Therapeutics, Inc. ) opening price: $126.3500

Yesterday's SRPT ( Sarepta Therapeutics, Inc. ) closing price: $125.3100

Sarepta Therapeutics, Inc. Stock ( symbol: SRPT ) Price Chart since IPO (2000):

12 Months Sarepta Therapeutics, Inc. Stock ( symbol: SRPT ) Price Chart

Popular Questions about Sarepta Therapeutics, Inc. Public Stock ( SRPT )

A: Sarepta Therapeutics, Inc. stock symbol (also called stock or share ticker) is SRPT

A: Sarepta Therapeutics, Inc. IPO (Initial Public Offering) took place on 2000

A: Sarepta Therapeutics, Inc.'s stock (SRPT symbol) price at ther IPO (initial Public Offering) was $126.3500

Q: Is SRPT stock worth buying at the moment?

A: The SRPT stock performance since 2019 are rather disappointing. If you had bought 1 share of Sarepta Therapeutics, Inc. stock (symbol: SRPT) at the beginning of 2019, at the opening share price of $139.7100, you would be left with exactly $126.3500 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Sarepta Therapeutics, Inc. Stock Easy Online

Sarepta Therapeutics, Inc. Stock Ticker Price Chart since IPO:





Sarepta Therapeutics, Inc. Stock Price Yesterday



 


Sarepta Therapeutics, Inc. Stock Price – Last Week




 


Sarepta Therapeutics, Inc. Stock Price – Last Month




 


Sarepta Therapeutics, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/31/1965463/0/en/Sarepta-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
                            

                                
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

                                
                                
CAMBRIDGE, Mass., Dec.  31, 2019  (GLOBE NEWSWIRE) -- Sarepta Thera...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/12/31/is-sarepta-therapeutics-stock-a-buy.aspx
                            

                                
Can Sarepta Therapeutics Stock Beat the Broader Markets in 2020?

                                
                                
Wall Street has high hopes for this mid-cap biotech in the coming y...


                            

                        
                    

                


                            

                    


                        
                            https://247wallst.com/healthcare-business/2019/12/30/why-one-analyst-sees-sareptas-roche-deal-taking-off/
                            

                                
Why One Analyst Sees Sarepta’s Roche Deal Taking Off

                                
                                
Sarepta Therapeutics Inc. (NASDAQ: SRPT) shares jumped last week on...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4314080-sarepta-therapeutics-continued-progress-in-duchenne-md
                            

                                
Sarepta Therapeutics: Continued Progress In Duchenne MD

                                
                                
Sarepta Therapeutics: Continued Progress In Duchenne MD


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/analyst-ratings/analyst-color/19/12/15038949/analysts-roche-partnership-derisks-sarepta-investor-concerns
                            

                                
Analysts: Roche Partnership Derisks Sarepta Investor Concerns

                                
                                
Sarepta Therapeutics Inc (NASDAQ: SRPT) has entered a partnership w...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/685750/sarepta-srpt-looks-good-stock-adds-75-in-session
                            

                                
Sarepta (SRPT) Looks Good: Stock Adds 7.5% in Session

                                
                                
Sarepta (SRPT) saw a big move last session, as its shares jumped mo...


                            

                        
                    

                


                            

                    


                        
                            https://247wallst.com/healthcare-business/2019/12/23/why-this-duchenne-muscular-dystropy-deal-could-be-huge/
                            

                                
Why This Duchenne Muscular Dystropy Deal Could Be Huge

                                
                                
Sarepta Therapeutics Inc. (NASDAQ: SRPT) shares made a handy gain t...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/684167/sarepta-signs-gene-therapy-agreement-with-roche-for-%24115b
                            

                                
Sarepta Signs Gene Therapy Agreement With Roche for $1.15B

                                
                                
Sarepta (SRPT) grants ex-U.S. marketing rights of its gene therapy ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/31/1965463/0/en/Sarepta-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
                            

                                
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

                                
                                
CAMBRIDGE, Mass., Dec.  31, 2019  (GLOBE NEWSWIRE) -- Sarepta Thera...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/12/31/is-sarepta-therapeutics-stock-a-buy.aspx
                            

                                
Can Sarepta Therapeutics Stock Beat the Broader Markets in 2020?

                                
                                
Wall Street has high hopes for this mid-cap biotech in the coming y...


                            

                        
                    

                


                            

                    


                        
                            https://247wallst.com/healthcare-business/2019/12/30/why-one-analyst-sees-sareptas-roche-deal-taking-off/
                            

                                
Why One Analyst Sees Sarepta’s Roche Deal Taking Off

                                
                                
Sarepta Therapeutics Inc. (NASDAQ: SRPT) shares jumped last week on...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4314080-sarepta-therapeutics-continued-progress-in-duchenne-md
                            

                                
Sarepta Therapeutics: Continued Progress In Duchenne MD

                                
                                
Sarepta Therapeutics: Continued Progress In Duchenne MD


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/analyst-ratings/analyst-color/19/12/15038949/analysts-roche-partnership-derisks-sarepta-investor-concerns
                            

                                
Analysts: Roche Partnership Derisks Sarepta Investor Concerns

                                
                                
Sarepta Therapeutics Inc (NASDAQ: SRPT) has entered a partnership w...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/685750/sarepta-srpt-looks-good-stock-adds-75-in-session
                            

                                
Sarepta (SRPT) Looks Good: Stock Adds 7.5% in Session

                                
                                
Sarepta (SRPT) saw a big move last session, as its shares jumped mo...


                            

                        
                    

                


                            

                    


                        
                            https://247wallst.com/healthcare-business/2019/12/23/why-this-duchenne-muscular-dystropy-deal-could-be-huge/
                            

                                
Why This Duchenne Muscular Dystropy Deal Could Be Huge

                                
                                
Sarepta Therapeutics Inc. (NASDAQ: SRPT) shares made a handy gain t...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.